Contineum Therapeutics Inc.

CTNM | NASDAQ

Price Alert Chart Builder DCF Calculator

$13.47

-$0.08 (-0.59%)

Sep 22, 2026, 2:40 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $509.77M

Enterprise Value $279.79M

Beta 0.75

Average Volume 364.33K

Shares Outstanding (Diluted) 37.47M

Shares Change YoY 44.69%

Institutional Ownership 81.83%

Exchange NASDAQ

ISIN US21217B1008

Price Performance

Price Change 1M -19.4%

Price Change 3M 13.8%

Price Change 6M 2.0%

Price Change YTD 19.0%

Price Change 1Y 20.2%

Price Change 3Y -12.0%

Price Change 5Y -12.0%

1M CAGR (ann.) -9.9%

1Y CAGR (ann.) 9.3%

5Y CAGR (ann.) N/A

All-Time CAGR -5.1%

Valuation

PE Ratio -7.83

Forward PE N/A

PEG Ratio -0.33

Forward PEG -0.52

PS Ratio N/A

Forward PS 231.70

PB Ratio 2.13

P/FCF Ratio -9.53

P/Adj. FCF Ratio -7.70

P/OCF Ratio -9.61

EV/Sales N/A

EV/EBIT -6.60

EV/EBITDA -4.70

EV/FCF -5.23

Earnings Yield -12.8%

FCF Yield -10.5%

Adj. FCF Yield -13.0%

Financial Health

Net Cash $229.98M

Total Debt $6.57M

Cash & Short-Term Investments $236.55M

Total Assets $250.37M

Current Ratio 37.17

Quick Ratio 37.17

Debt / Equity Ratio 0.03

Debt / EBITDA -0.11

Debt / FCF -0.12

OCF / Debt -8.06

Interest Coverage 0.00

Altman Z-Score 27.98

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -23.8%

Returns

Return on Assets -23.0%

Return on Equity -24.7%

Return on Invested Capital -27.0%

Return on Capital Employed -27.2%

Return on Tangible Assets -23.0%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -22.9%

EPS CAGR 5Y N/A

EPS CAGR 10Y N/A

FCF CAGR 3Y -22.8%

FCF CAGR 5Y N/A

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 4

EPS Growth Next 3Y -6.9%

Revenue Growth Next 3Y N/A

Earnings Date Oct 28, 2026

EPS Estimate (next Q) -$0.45

EPS Growth Est (next Q) 0.0%

Revenue Est (next Q) $5.65M

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $17.50

Price Target Upside 29.2%

Cash Flow

Operating Cash Flow $-53.01M

Free Cash Flow $-53.46M

Adj. Free Cash Flow $-66.18M

FCF Per Share -$1.43

OCF Per Share -$1.41

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-66.38M

EBITDA $-59.58M

Net Income $-57.56M

EPS (Diluted) -$1.73

Revenue / Employee N/A

Profit / Employee $-1.13M

Employees 51